Who are Vitamin C 1 GM Oral Tablet's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): SODIUM ASCORBATE, Infuvite Adult, Infuvite Adult, Glucoferron, Hectorol, Zemplar.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/vitamin-c-1-gm-oral-tablet.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Vitamin C 1 GM Oral Tablet — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vitamin C 1 GM Oral Tablet (Vitamin C 1 GM Oral Tablet) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin. Area: Nutritional deficiencies.

phase 3 Vitamin Nutritional deficiencies Small molecule Live · refreshed every 30 min

Target snapshot

Vitamin C 1 GM Oral Tablet (Vitamin C 1 GM Oral Tablet) — American British Cowdray Medical Center. Vitamin C acts as an antioxidant and is involved in various enzymatic reactions.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Vitamin C 1 GM Oral Tablet TARGET	Vitamin C 1 GM Oral Tablet	American British Cowdray Medical Center	phase 3	Vitamin
SODIUM ASCORBATE	SODIUM ASCORBATE		marketed	Vitamin D [EPC]		2006-01-01
Infuvite Adult	Colecalciferol	Novartis	marketed	Vitamin D	Vitamin D3 receptor	2000-01-01
Infuvite Adult	alpha-tocopherol acetate	Novartis	marketed	Vitamin C [EPC]		2000-01-01
Glucoferron	FERROUS GLUCONATE	Sanofi	marketed	Vitamin C [EPC]		1999-01-01
Hectorol	DOXERCALCIFEROL	Sanofi	marketed	Vitamin D2 Analog [EPC]	Vitamin D3 receptor	1999-01-01
Zemplar	PARICALCITOL	AbbVie	marketed	Vitamin D2 Analog [EPC]	Vitamin D3 receptor	1998-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin class)

American British Cowdray Medical Center · 1 drug in this class
National Institute of Neurological Disorders and Stroke (NINDS) · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vitamin C 1 GM Oral Tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-c-1-gm-oral-tablet. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab